These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35688320)

  • 1. Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer.
    Tosti E; Almeida AS; Tran TTT; Barbachan E Silva M; Broin PÓ; Dubin R; Chen K; Beck AP; Mclellan AS; Vilar E; Golden A; O'Toole PW; Edelmann W
    Cell Mol Gastroenterol Hepatol; 2022; 14(3):693-717. PubMed ID: 35688320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.
    Kucherlapati MH; Lee K; Nguyen AA; Clark AB; Hou H; Rosulek A; Li H; Yang K; Fan K; Lipkin M; Bronson RT; Jelicks L; Kunkel TA; Kucherlapati R; Edelmann W
    Gastroenterology; 2010 Mar; 138(3):993-1002.e1. PubMed ID: 19931261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
    Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
    Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsatellite instability: an update.
    Yamamoto H; Imai K
    Arch Toxicol; 2015 Jun; 89(6):899-921. PubMed ID: 25701956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome.
    Lang M; Baumgartner M; Rożalska A; Frick A; Riva A; Jarek M; Berry D; Gasche C
    Int J Cancer; 2020 Oct; 147(8):2316-2326. PubMed ID: 32350866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
    Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
    Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
    Fricke F; Lee J; Michalak M; Warnken U; Hausser I; Suarez-Carmona M; Halama N; Schnölzer M; Kopitz J; Gebert J
    Cell Commun Signal; 2017 Apr; 15(1):14. PubMed ID: 28376875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.
    Poulogiannis G; Frayling IM; Arends MJ
    Histopathology; 2010 Jan; 56(2):167-79. PubMed ID: 20102395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer.
    Lee CT; Chow NH; Chen YL; Ho CL; Yeh YM; Lin SC; Lin PC; Lin BW; Chu CA; Tsai HW; Lee JC
    Pathol Res Pract; 2021 Jan; 217():153288. PubMed ID: 33276219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetaldehyde and defective mismatch repair increase colonic tumours in a Lynch syndrome model with Aldh1b1 inactivation.
    Cerretelli G; Zhou Y; Müller MF; Adams DJ; Arends MJ
    Dis Model Mech; 2023 Aug; 16(8):. PubMed ID: 37395714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells.
    Bommi PV; Bowen CM; Reyes-Uribe L; Wu W; Katayama H; Rocha P; Parra ER; Francisco-Cruz A; Ozcan Z; Tosti E; Willis JA; Wu H; Taggart MW; Burks JK; Lynch PM; Edelmann W; Scheet PA; Wistuba II; Sinha KM; Hanash SM; Vilar E
    Cancer Res; 2021 May; 81(10):2760-2773. PubMed ID: 34003775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
    Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
    Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
    Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
    Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol-induced formation of colorectal tumours and precursors in a mouse model of Lynch syndrome.
    Cerretelli G; Zhou Y; Müller MF; Adams DJ; Arends MJ
    J Pathol; 2021 Dec; 255(4):464-474. PubMed ID: 34543445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
    Vyas M; Firat C; Hechtman JF; Weiser MR; Yaeger R; Vanderbilt C; Benhamida JK; Keshinro A; Zhang L; Ntiamoah P; Gonzalez M; Andrade R; El Dika I; Markowitz AJ; Smith JJ; Garcia-Aguilar J; Vakiani E; Klimstra DS; Stadler ZK; Shia J
    Fam Cancer; 2021 Jul; 20(3):201-213. PubMed ID: 33033905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.
    Ten Broeke SW; van Bavel TC; Jansen AML; Gómez-García E; Hes FJ; van Hest LP; Letteboer TGW; Olderode-Berends MJW; Ruano D; Spruijt L; Suerink M; Tops CM; van Eijk R; Morreau H; van Wezel T; Nielsen M
    Gastroenterology; 2018 Sep; 155(3):844-851. PubMed ID: 29758216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.
    Aslanian HR; Burgart LJ; Harrington JJ; Mahoney DW; Zinsmeister AR; Thibodeau SN; Ahlquist DA
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1385-8. PubMed ID: 18639494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.